The Covid-19 outbreak has started a challenging trial run of working remotely. However, our employees are rising up to this challenge. We take our shared responsibility seriously and protect our employees by applying the appropriate health instructions and by minimizing on-site staffing. In turn, our employees are working through the crisis with unflagging dedication to serve our patients in need.
We have a number of products in our portfolio that are essential in treating severe pathologies developed by a significant number of patients admitted to intensive care units in the context of the current pandemic.
We place our trust in our ongoing cooperation with our partners to ensure Eumedica’s medical care continuity across the globe.
As a pharmaceutical company, Eumedica AG ensures the continuity of access to quality & lifesaving therapeutic solutions for healthcare practitioners and patients.
We focus on developing and maintaining a diversified range of therapeutic solutions that cover critical unmet medical needs.
Eumedica AG continuously develops its product portfolio of original drugs, actively used in hospitals as well as in retail channels.
Our product portfolio is made available worldwide thanks to a broad network of distributors and licensors.